These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15622326

  • 1. CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
    Kakuda TN, Anderson PL, Becker SL.
    AIDS; 2004 Dec 03; 18(18):2442-4. PubMed ID: 15622326
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
    Atta MG, Fine DM.
    AIDS Read; 2009 Mar 03; 19(3):118-9. PubMed ID: 19334329
    [No Abstract] [Full Text] [Related]

  • 4. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM, Dwyer JP, Brumble LM, Alvarez S, Mendez JC.
    AIDS Read; 2009 Mar 03; 19(3):114-21. PubMed ID: 19334328
    [Abstract] [Full Text] [Related]

  • 5. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
    Sax PE.
    AIDS Clin Care; 2005 Jan 03; 17(1):6-7. PubMed ID: 15717372
    [No Abstract] [Full Text] [Related]

  • 6. Tenofovir and didanosine: a dangerous liaison.
    Waters L, Maitland D, Moyle GJ.
    AIDS Read; 2005 Aug 03; 15(8):403-6, 413. PubMed ID: 16110555
    [No Abstract] [Full Text] [Related]

  • 7. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
    Kearney BP, Sayre JR, Flaherty JF, Chen SS, Kaul S, Cheng AK.
    J Clin Pharmacol; 2005 Dec 03; 45(12):1360-7. PubMed ID: 16291710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adverse events experienced by three children taking tenofovir and didanosine in combination.
    Hawkins S, Ball C.
    HIV Med; 2007 Sep 03; 8(6):411. PubMed ID: 17661851
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
    Gallant JE, Parish MA, Keruly JC, Moore RD.
    Clin Infect Dis; 2005 Apr 15; 40(8):1194-8. PubMed ID: 15791522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: a case control study.
    Cotte L, Bénet T, Billioud C, Miailhes P, Scoazec JY, Ferry T, Brochier C, Boibieux A, Vanhems P, Chevallier M, Zoulim F.
    J Hepatol; 2011 Mar 15; 54(3):489-96. PubMed ID: 21056493
    [Abstract] [Full Text] [Related]

  • 20. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
    de la Prada FJ, Prados AM, Tugores A, Uriol M, Saus C, Morey A.
    Nefrologia; 2006 Mar 15; 26(5):626-30. PubMed ID: 17117909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.